LexDanaLexDanabeta
Inventor

TOSHIHIKO SONE

Inventor
JP

Overview

2→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium25%
PatentTitleYear
12,295,947Tetrahydroquinoline derivatives as P2X7 receptor antagonists202511,439,633Tetrahydroquinoline derivatives as P2X7 receptor antagonists2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to ASAHI KASEI PHARMA CORP (2)· patent assignee history
2022–2025Patents assigned to RAQUALIA PHARMA INC (2)· patent assignee history
2022–2025Based in JP· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ASAHI KASEI PHARMA CORP22022–2025
RAQUALIA PHARMA INC22022–2025
Locations
LocationPatentsSpan
JP22022–2025